Rockefeller Capital Management L.P. Purchases 441,154 Shares of Solana Company $HSDT

Rockefeller Capital Management L.P. grew its holdings in shares of Solana Company (NASDAQ:HSDT) by 11,764.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 444,904 shares of the company’s stock after acquiring an additional 441,154 shares during the period. Rockefeller Capital Management L.P.’s holdings in Solana were worth $1,286,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Grant Private Wealth Management Inc acquired a new position in shares of Solana in the 4th quarter valued at about $46,000. Quattro Financial Advisors LLC acquired a new stake in Solana during the fourth quarter worth approximately $604,000. Franchise GP Ltd bought a new stake in Solana in the fourth quarter worth approximately $653,000. Geode Capital Management LLC bought a new stake in Solana in the fourth quarter worth approximately $1,006,000. Finally, LPL Financial LLC lifted its stake in Solana by 120.1% in the fourth quarter. LPL Financial LLC now owns 382,255 shares of the company’s stock valued at $1,105,000 after buying an additional 208,558 shares during the period. 18.63% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on HSDT. B. Riley Financial started coverage on shares of Solana in a research note on Thursday, April 23rd. They issued a “buy” rating and a $3.00 price objective for the company. Weiss Ratings restated a “sell (e+)” rating on shares of Solana in a report on Tuesday, April 21st. Zacks Research raised shares of Solana to a “hold” rating in a research note on Monday, April 27th. Finally, Maxim Group started coverage on shares of Solana in a report on Monday, April 6th. They set a “buy” rating and a $4.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Solana has a consensus rating of “Moderate Buy” and an average price target of $3.50.

Solana Stock Up 5.5%

Shares of NASDAQ:HSDT opened at $1.74 on Thursday. Solana Company has a twelve month low of $1.19 and a twelve month high of $25.50. The stock’s 50 day moving average is $1.89 and its 200-day moving average is $2.25. The firm has a market capitalization of $101.60 million, a price-to-earnings ratio of -0.02 and a beta of 1.03.

Solana (NASDAQ:HSDT) last issued its earnings results on Friday, May 15th. The company reported ($1.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.96). Solana had a negative return on equity of 67.57% and a negative net margin of 1,427.15%.The firm had revenue of $3.62 million during the quarter, compared to the consensus estimate of $3.40 million. Equities research analysts anticipate that Solana Company will post -0.09 earnings per share for the current fiscal year.

Solana Profile

Helius Medical Technologies, Inc (NASDAQ: HSDT) is a medical technology company focused on developing and commercializing non‐invasive neuromodulation platforms designed to enhance neurorehabilitation. Its flagship product, the Portable Neuromodulation Stimulator (PoNS®), delivers mild electrical pulses to the tongue to stimulate neural pathways in conjunction with targeted physical therapy. The device is intended to improve neuroplasticity and support recovery in patients with neurological conditions.

The PoNS system is cleared for use in the United States, Canada and the European Union and is prescribed through specialized rehabilitation clinics.